These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 21282423)
1. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components. Yoneyama F; Ohno K; Imura Y; Li M; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K Antimicrob Agents Chemother; 2011 May; 55(5):2446-50. PubMed ID: 21282423 [TBL] [Abstract][Full Text] [Related]
2. Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q. Li M; Yoneyama F; Toshimitsu N; Zendo T; Nakayama J; Sonomoto K Antimicrob Agents Chemother; 2013 Aug; 57(8):3897-902. PubMed ID: 23733459 [TBL] [Abstract][Full Text] [Related]
3. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Yoneyama F; Imura Y; Ohno K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K Antimicrob Agents Chemother; 2009 Aug; 53(8):3211-7. PubMed ID: 19470516 [TBL] [Abstract][Full Text] [Related]
4. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Yoneyama F; Imura Y; Ichimasa S; Fujita K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K Appl Environ Microbiol; 2009 Jan; 75(2):538-41. PubMed ID: 19011053 [TBL] [Abstract][Full Text] [Related]
5. Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14. Iwatani S; Zendo T; Yoneyama F; Nakayama J; Sonomoto K Biosci Biotechnol Biochem; 2007 Aug; 71(8):1984-92. PubMed ID: 17690480 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting bacterial colonization on catheters: Antibacterial and antibiofilm activities of bacteriocins from Lactobacillus plantarum SJ33. Ray Mohapatra A; Jeevaratnam K J Glob Antimicrob Resist; 2019 Dec; 19():85-92. PubMed ID: 30853461 [TBL] [Abstract][Full Text] [Related]
7. Effect of a negatively charged lipid on membrane-lacticin Q interaction and resulting pore formation. Yoneyama F; Shioya K; Zendo T; Nakayama J; Sonomoto K Biosci Biotechnol Biochem; 2010; 74(1):218-21. PubMed ID: 20057115 [TBL] [Abstract][Full Text] [Related]
8. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria. Heselpoth RD; Euler CW; Schuch R; Fischetti VA Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344 [TBL] [Abstract][Full Text] [Related]
9. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. McAuliffe O; Ryan MP; Ross RP; Hill C; Breeuwer P; Abee T Appl Environ Microbiol; 1998 Feb; 64(2):439-45. PubMed ID: 9464377 [TBL] [Abstract][Full Text] [Related]
10. Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Galvin M; Hill C; Ross RP Lett Appl Microbiol; 1999 May; 28(5):355-8. PubMed ID: 10347889 [TBL] [Abstract][Full Text] [Related]
11. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. Draper LA; Cotter PD; Hill C; Ross RP BMC Microbiol; 2013 Sep; 13():212. PubMed ID: 24069959 [TBL] [Abstract][Full Text] [Related]
12. The introduction of L-phenylalanine into antimicrobial peptide protonectin enhances the selective antibacterial activity of its derivative phe-Prt against Gram-positive bacteria. Peng J; Qiu S; Jia F; Zhang L; He Y; Zhang F; Sun M; Deng Y; Guo Y; Xu Z; Liang X; Yan W; Wang K Amino Acids; 2021 Jan; 53(1):23-32. PubMed ID: 33236256 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of oxa-lacticin A2, a lantibiotic analogue with sulfur replaced by oxygen. Liu H; Pattabiraman VR; Vederas JC Org Lett; 2009 Dec; 11(24):5574-7. PubMed ID: 19921853 [TBL] [Abstract][Full Text] [Related]
15. The outer membrane of gram-negative bacteria inhibits antibacterial activity of brochocin-C. Gao Y; van Belkum MJ; Stiles ME Appl Environ Microbiol; 1999 Oct; 65(10):4329-33. PubMed ID: 10508055 [TBL] [Abstract][Full Text] [Related]
16. Class III bacteriocin Helveticin-M causes sublethal damage on target cells through impairment of cell wall and membrane. Sun Z; Wang X; Zhang X; Wu H; Zou Y; Li P; Sun C; Xu W; Liu F; Wang D J Ind Microbiol Biotechnol; 2018 Mar; 45(3):213-227. PubMed ID: 29349568 [TBL] [Abstract][Full Text] [Related]
18. Developing applications for lactococcal bacteriocins. Ross RP; Galvin M; McAuliffe O; Morgan SM; Ryan MP; Twomey DP; Meaney WJ; Hill C Antonie Van Leeuwenhoek; 1999; 76(1-4):337-46. PubMed ID: 10532388 [TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of cerein 7, a new bacteriocin produced by Bacillus cereus with a broad spectrum of activity. Oscáriz JC; Lasa I; Pisabarro AG FEMS Microbiol Lett; 1999 Sep; 178(2):337-41. PubMed ID: 10499284 [TBL] [Abstract][Full Text] [Related]
20. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria. Chi H; Holo H Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]